AEAnthony EnimilMDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Transition of Youth Living With HIV to Adult Care: High-Resource Country Experience - Caroline FosterView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Effectiveness and Safety of Tenofovir Alafenamide Fumarate (TAF)-Based Therapy Compared to Tenofovir Disoproxil Fumarate (TDF)- And Abacavir (ABC)-Based Therapy in Children and Adolescents Living With HIV (CALHIV) (...) - Elizabeth ChappellView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#19 - Adolescents and Young Adults with HIV Using Long-Acting Injectable Cabotegravir/Rilpivirine as a Standard of Care: Outcomes of the Observational Cohort at 26 months - Tierra WilliamsView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#18 - Concerning Lack of Virological Suppression in Plasma and Cerebrospinal Fluid in Adolescents on Long-term Early Antiretroviral Therapy - Barbara LaughtonView Video
CLCarmen LogieMSW, PhDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#17 - Findings From the Todurujo NA Kadurok (Empowering Youth) HIV Self-Testing and Edutainment Comic Randomized Controlled Trial With Refugee Youth in a Humanitarian Setting in Uganda - Carmen LogieView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#16 - A Multi-Country Analysis of HIV Testing Strategies for Identifying Adolescents Living With HIV - Deborah CarpenterView Video
MCMark CottonMD, PhDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Update on Analytic Treatment Interruption Consensus Guidelines for HIV Cure/Control - Mark CottonView Video
DPDeborah PersaudMDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024Update on Cure Agenda - Deborah PersaudView Video
MCMark CottonMD, PhDVideoHIVRSVInternational Workshop on Pediatrics & HIV 2024From CHER to Cure: How a Pivotal Trial Helped to Shape the HIV Cure/Control Agenda in Children & Adolescents - Mark CottonView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#24 - In-Utero Exposure to High Tenofovir Concentration Is Associated With Lower Bone Mineral Content in HIV-Unexposed Infants - Kimesh - NaidooView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#23 - Genotypic Resistance to Integrase Inhibitors, Protease Inhibitors and Tenofovir Alafenamide Is Uncommon in Children With Virological Rebound in the CHAPAS-4 Randomised Trial of Second-Line Antiretroviral Therapy for Children With HIV - Cissy KityoView Video
VideoHIVRSVInternational Workshop on Pediatrics & HIV 2024#22 - Trends in Infant HIV Positivity and Linkage to ART among HIV-Exposed Infants Aged <12 Months in PEPFAR-Supported Programs, FY2018-FY2023 - Elizabeth M. RaboldView Video
